{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T17:17:17Z","timestamp":1775063837585,"version":"3.50.1"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.semarthrit.2022.152026","type":"journal-article","created":{"date-parts":[[2022,5,18]],"date-time":"2022-05-18T11:34:26Z","timestamp":1652873666000},"page":"152026","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Scleroderma-specific autoantibodies: Should they be included in the diagnostic work-up for Sj\u00f6gren's syndrome?"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6995-3713","authenticated-orcid":false,"given":"Nikolaos","family":"Marketos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasiliki","family":"Koulouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evangelia P.","family":"Piperi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria E.","family":"Georgaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikolaos G.","family":"Nikitakis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clio P.","family":"Mavragani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2022.152026_bib0001","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1001\/archinte.164.12.1275","article-title":"Clinical manifestations and early diagnosis of sj\u00f6gren syndrome","volume":"164","author":"Kassan","year":"2004","journal-title":"Arch Intern Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152026_bib0002","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/art.39859","article-title":"2016 American college of rheumatology\/european league against rheumatism classification criteria for primary Sj\u00f6gren's syndrome: a consensus and data-driven methodology involving three international patient cohorts","volume":"69","author":"Shiboski","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152026_bib0003","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/rheumatology\/41.4.416","article-title":"Dry eyes and mouth syndrome - a subgroup of patients presenting with sicca symptoms","volume":"41","author":"Price","year":"2002","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152026_bib0004","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1093\/rheumatology\/keg226","article-title":"Dry eyes and mouth syndrome or sicca, asthenia and polyalgia syndrome? [11]","volume":"42","author":"Mariette","year":"2003","journal-title":"Rheumatology"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152026_bib0005","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.3899\/jrheum.081326","article-title":"Increased prevalence of antibodies to thyroid peroxidase in dry eyes and mouth syndrome or sicca asthenia polyalgia syndrome","volume":"36","author":"Mavragani","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152026_bib0006","article-title":"Clinical influences of anticentromere antibody on primary Sj\u00f6gren's syndrome in a prospective Korean cohort","author":"Park","year":"2020","journal-title":"Korean J Intern Med"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152026_bib0007","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/rheumatology\/32.4.297","article-title":"Patients with anticentromere antibodies clinical features, diagnoses and evolution","volume":"32","author":"Vlachogiannopoulos","year":"1993","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2022.152026_bib0008","doi-asserted-by":"crossref","first-page":"707","DOI":"10.7326\/0003-4819-87-6-707","article-title":"Scleroderma, sjogren-like syndrome, and chronic graft- versus-host disease","volume":"87","author":"Lawley","year":"1977","journal-title":"Ann Intern Med"},{"issue":"8","key":"10.1016\/j.semarthrit.2022.152026_bib0009","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1136\/ard.2005.046003","article-title":"Distinct recognition of antibodies to centromere proteins in primary Sj\u00f6gren's syndrome compared with limited scleroderma","volume":"65","author":"Gelber","year":"2006","journal-title":"Ann Rheum Dis"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152026_bib0010","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.semarthrit.2005.12.004","article-title":"Atypical autoantibodies in patients with primary sj\u00f6gren syndrome: clinical characteristics and follow-up of 82 cases","volume":"35","author":"Ramos-Casals","year":"2006","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152026_bib0011","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s40744-018-0126-2","article-title":"Clinical and immunological features of anti-centromere antibody-positive primary Sj\u00f6gren's syndrome","volume":"5","author":"Tsukamoto","year":"2018","journal-title":"Rheumatol Ther"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152026_bib0012","doi-asserted-by":"crossref","DOI":"10.1186\/ar2958","article-title":"Anticentromere antibody positive Sj\u00f6gren's Syndrome: a retrospective descriptive analysis","volume":"12","author":"Bournia","year":"2010","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.semarthrit.2022.152026_bib0013","first-page":"163","article-title":"Editorial Anticentromere (ACA) -positive Sj\u04e7gren \u2019 s syndrome\u00a0: a disease entity\u00a0?","volume":"31","author":"Vlachoyiannopoulos","year":"2013","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152026_bib0014","doi-asserted-by":"crossref","DOI":"10.1136\/annrheumdis-2021-eular.1110","article-title":"Clinical characteristics associated with glandural involvement evaluated by salivary gland ultrasonography in Sj\u00f6gren's syndrome","author":"Shimizu","year":"2021","journal-title":"Annals of the Rheumatic Disease"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152026_bib0015","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s12016-018-8718-8","article-title":"Antinuclear antibodies in systemic sclerosis: an update","volume":"58","author":"Stochmal","year":"2020","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152026_bib0016","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3109\/08916930008994077","article-title":"Comparison of the anti-Ro\/SSA autoantibody profile between patients with primary and secondary Sjogren's syndrome","volume":"32","author":"Gal","year":"2000","journal-title":"Autoimmunity"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152026_bib0017","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0030-4220(74)90417-4","article-title":"The histopathology of Sj\u00f6gren's syndrome in labial salivary gland biopsies. Oral Surgery","volume":"37","author":"Greenspan","year":"1974","journal-title":"Oral Med Oral Pathol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152026_bib0018","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/eurheartj\/ehv317","article-title":"2015 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"37","author":"Gali\u00e8","year":"2016","journal-title":"Eur Heart J"},{"issue":"25","key":"10.1016\/j.semarthrit.2022.152026_bib0019","doi-asserted-by":"crossref","first-page":"e3766","DOI":"10.1097\/MD.0000000000003766","article-title":"Predicting the risk for lymphoma development in Sj\u00f6gren syndrome: an easy tool for clinical use","volume":"95","author":"Fragkioudaki","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"1\u20132","key":"10.1016\/j.semarthrit.2022.152026_bib0020","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.jaut.2012.03.001","article-title":"Subgroups of Sj\u00f6gren syndrome patients according to serological profiles","volume":"39","author":"Bournia","year":"2012","journal-title":"J Autoimmun"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152026_bib0021","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1002\/acr.22859","article-title":"Association of anticentromere antibodies with more severe exocrine glandular dysfunction in Sj\u00f6gren's syndrome: analysis of the sj\u00f6gren's international collaborative clinical alliance cohort","volume":"68","author":"Baer","year":"2016","journal-title":"Arthritis Care Res"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152026_bib0022","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1365-2230.1994.tb01199.x","article-title":"Anticentromere antibodies (ACA): clinical distribution and disease specificity","volume":"19","author":"Chan","year":"1994","journal-title":"Clin Exp Dermatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152026_bib0023","first-page":"0273","article-title":"Overlap of aca-positive systemic sclerosis and Sj\u00f6gren's syndrome: a distinct clinical entity with mild organ involvement but at high risk of lymphoma","volume":"31","author":"Baldini","year":"2013","journal-title":"Clin Exp Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152026_bib0024","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10067-011-1789-z","article-title":"Clinical significance and diagnostic usefulness of anti-centromere antibody in Sj\u00f6gren's syndrome","volume":"31","author":"Kitagawa","year":"2012","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152026_bib0025","first-page":"75","article-title":"Primary biliary cirrhosis and the crest syndrome: a report of 22 cases","volume":"62","author":"Powell","year":"1987","journal-title":"QJM"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152026_bib0026","first-page":"2253","article-title":"Anticentromere antibodies identify patients with Sj\u00f6gren's syndrome and autoimmune overlap syndrome","volume":"34","author":"Salliot","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152026_bib0027","first-page":"S145","article-title":"A clinical and histopathological analysis of the anti-centromere antibody positive subset of primary Sj\u00f6gren's syndrome","volume":"36","author":"Notarstefano","year":"2018","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152026_bib0028","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1002\/art.21922","article-title":"Systemic sclerosis-associated Sj\u00f6gren's syndrome and relationship to the limited cutaneous subtype: results of a prospective study of sicca syndrome in 133 consecutive patients","volume":"54","author":"Avouac","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152026_bib0029","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/kel252","article-title":"Sj\u00f6gren's syndrome is associated with and not secondary to systemic sclerosis","volume":"46","author":"Salliot","year":"2007","journal-title":"Rheumatology"},{"issue":"7","key":"10.1016\/j.semarthrit.2022.152026_bib0030","first-page":"1419","article-title":"Anti-centromere autoantibody in a patient evolving from a lupus\/Sj\u00f6gren's overlap to the CREST variant of scleroderma","volume":"25","author":"Ford","year":"1998","journal-title":"J Rheumatol"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152026_bib0031","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1080\/24725625.2020.1755516","article-title":"A case report, a case who developed limited cutaneous scleroderma and pulmonary hypertension 8 years after diagnosis of anti-centromere antibody-positive Sj\u00f6gren syndrome","volume":"4","author":"Kyono","year":"2020","journal-title":"Mod Rheumatol Case Reports"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152026_bib0032","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1111\/j.1445-5994.2008.01636.x","article-title":"Prevalence of SICCA symptoms in a South Australian cohort with systemic sclerosis","volume":"38","author":"Swaminathan","year":"2008","journal-title":"Intern Med J"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152026_bib0033","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1756-185X.2012.01810.x","article-title":"The frequency of sicca symptoms and Sj\u00f6gren's syndrome in patients with systemic sclerosis","volume":"16","author":"Kobak","year":"2013","journal-title":"Int J Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152026_bib0034","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.3906\/sag-2012-25","article-title":"The prevalence of Sj\u00f6gren's syndrome and SICCA symptoms in patients with systemic sclerosis and alpha-smooth muscle actin expression in biopsy specimens from minor salivary glands","volume":"51","author":"Can","year":"2021","journal-title":"Turkish J Med Sci"},{"issue":"1","key":"10.1016\/j.semarthrit.2022.152026_bib0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/0002-9343(74)90771-2","article-title":"Sj\u00f6gren's syndrome in progressive systemic sclerosis (scleroderma)","volume":"57","author":"Alarc\u00f3n-Segovia","year":"1974","journal-title":"Am J Med"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152026_bib0036","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1590\/S1807-59322011000300003","article-title":"Ocular findings in patients with systemic sclerosis","volume":"66","author":"Gomes B de","year":"2011","journal-title":"Clinics"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152026_bib0037","doi-asserted-by":"crossref","first-page":"535","DOI":"10.7326\/0003-4819-87-5-535","article-title":"Sjogren's syndrome in progressive systemic sclerosis","volume":"87","author":"Cipoletti","year":"1977","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152026_bib0038","first-page":"965","article-title":"Sjogren's syndrome in progressive systemic sclerosis","volume":"15","author":"Drosos","year":"1988","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2022.152026_bib0039","first-page":"45","volume":"249","author":"Beigelman","year":"1953","journal-title":"Progressive Systemic Sclerosis (Scleroderma)"},{"issue":"3","key":"10.1016\/j.semarthrit.2022.152026_bib0040","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1159\/000255579","article-title":"Diffuse scleroderma","volume":"117","author":"\u0160\u0164\u00e1va","year":"1958","journal-title":"Dermatology"},{"key":"10.1016\/j.semarthrit.2022.152026_bib0041","first-page":"301","article-title":"The natural history of progressive systemic sclerosis (diffuse scleroderma)","volume":"13","author":"Rodnan","year":"1963","journal-title":"Bull Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152026_bib0042","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.oooo.2021.03.014","article-title":"Labial salivary gland assessment in idiopathic pulmonary fibrosis patients with sicca symptoms","volume":"132","author":"Bawazir","year":"2021","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152026_bib0043","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1136\/annrheumdis-2019-215777","article-title":"Do the salivary glands of patients with systemic sclerosis show ultrasonographic modifications suggestive of Sj\u00f6gren's syndrome?","volume":"79","author":"Couderc","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"10.1016\/j.semarthrit.2022.152026_bib0044","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1136\/annrheumdis-2019-215797","article-title":"Sicca: an important manifestation of damage in systemic sclerosis (SSc) and SSc-overlap syndromes. Response to: do the salivary glands of patients with systemic sclerosis show ultrasonographic modifications suggestive of Sj\u00f6gren's syndrome?\u2019 by Coudrec e","volume":"79","author":"Nikpour","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2022.152026_bib0045","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1136\/annrheumdis-2018-214764","article-title":"Development and validation of the scleroderma clinical trials consortium damage index (SCTC-DI): a novel instrument to quantify organ damage in systemic sclerosis","volume":"78","author":"Ferdowsi","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152026_bib0046","first-page":"321","article-title":"Muscarinic acetylcholine receptor antibodies as a new marker of dry eye Sj\u00f6gren syndrome","volume":"42","author":"Bacman","year":"2001","journal-title":"Investig Ophthalmol Vis Sci"},{"issue":"5","key":"10.1016\/j.semarthrit.2022.152026_bib0047","first-page":"322","article-title":"Manifestations orofaciales de la scl\u00e9rodermie. Revue de la litt\u00e9rature","volume":"117","author":"Hadj Said","year":"2016","journal-title":"Rev Stomatol Chir Maxillofac Chir Orale"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152026_bib0048","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/rmdopen-2020-001516","article-title":"Application of the OMERACT Grey-scale Ultrasound Scoring System for salivary glands in a single-centre cohort of patients with suspected Sj\u00f6gren's syndrome","volume":"7","author":"Fana","year":"2021","journal-title":"RMD Open"},{"issue":"11","key":"10.1016\/j.semarthrit.2022.152026_bib0049","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1136\/annrheumdis-2017-211250","article-title":"Ultrasonography of major salivary glands compared with parotid and labial gland biopsy and classification criteria in patients with clinically suspected primary Sj\u00f6gren's syndrome","volume":"76","author":"Mossel","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"12","key":"10.1016\/j.semarthrit.2022.152026_bib0050","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1136\/annrheumdis-2019-215972","article-title":"Ultrasonographic salivary gland evaluation in systemic sclerosis: is sicca syndrome secondary to an authentic overlap syndrome or another specific fibrotic manifestation of the disease?","volume":"79","author":"Coiffier","year":"2020","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"10.1016\/j.semarthrit.2022.152026_bib0051","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2020.105113","article-title":"High prevalence of salivary gland ultrasound abnormalities in systemic sclerosis","volume":"88","author":"Lee","year":"2021","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.semarthrit.2022.152026_bib0052","first-page":"0","article-title":"Histopathology, salivary flow and ultrasonography of the parotid gland: three complementary measurements in primary Sj\u00f6gren's syndrome","volume":"1","author":"Mossel","year":"2021","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.semarthrit.2022.152026_bib0053","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1002\/art.1780260408","article-title":"Clinical and serologic study of sj\u00f6gren's syndrome in patients with progressive systemic sclerosis","volume":"26","author":"Osial","year":"1983","journal-title":"Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222000774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017222000774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T17:10:05Z","timestamp":1758733805000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017222000774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":53,"alternative-id":["S0049017222000774"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152026","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scleroderma-specific autoantibodies: Should they be included in the diagnostic work-up for Sj\u00f6gren's syndrome?","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2022.152026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"152026"}}